Critical Care Patients Benefit From Restrictive Transfusion
Although a restrictive transfusion strategy significantly reduces the risk for 30-day all-cause mortality in critical care patients, its benefits are less clear in perioperative patients, according to a meta-analysis by a Canadian research team.

“Although packed red blood cells are arguably the best therapy to use when you have a problem with oxygen-carrying capacity, they come with a couple risks, such as the potential for transfusion reactions and infectious disease transmission,” said Matthew Chong, MD, a resident at Western University, in London, Ontario. “Furthermore, they’re also costly, at $300 to $500 U.S. dollars, to give a patient a unit of blood. Finally, the products have a limited shelf life and supply...